SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — Judy Garland

PatientJudy Garland
Date of birth1993-06-10
IdentifiersMRN HR-ML005-SYN; SSN (made up) 000-05-6127
Document date2026-08-17
AuthorMargaret Ellsworth-Diaz, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Hoarse voice and sore throat for three days, during rehearsals. [S]

History of Present Illness

Ms. Garland asked for a same-day visit because her voice has been hoarse for three days. It began with a sore throat and a runny nose after several people in her rehearsal company had colds. Yesterday her voice cracked on high notes and today she can speak only quietly. She has a mild dry cough, worse at night, and felt warm yesterday. She has no trouble swallowing or breathing, no drooling, no neck swelling, and no heartburn. She has kept singing in rehearsals. She is taking phenobarbital 64.8 mg a day, and her next planned step down is due today. She asked for a steroid shot to get her voice back for rehearsals and for codeine cough syrup to help her sleep through the cough. She has taken no other medicine for it. [S]

ElementDetail
OnsetThree days ago, after a cold
LocationThroat and voice
DurationThree days
CharacterHoarse, quiet voice; scratchy sore throat
SeverityModerate; can speak quietly but cannot sing
TimingConstant; cough worse at night
ContextColds in her rehearsal company; she kept singing in rehearsals
Modifying factorsBetter with warm drinks; worse with singing
Associated signs and symptomsRunny nose, mild dry cough, felt warm; no trouble swallowing or breathing, no drooling, no heartburn

Review of Systems

SystemResultFinding
ConstitutionalPositiveFelt warm yesterday; no rigors
Ears, nose, mouth, and throatPositiveHoarse voice, sore throat and runny nose; no trouble swallowing, no ear pain
RespiratoryPositiveMild dry cough; no breathlessness or wheeze
PsychiatricPositiveWorried about rehearsals and about sleeping with the cough; no thoughts of suicide or self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Secobarbital 100 mg oral capsule, two capsules (200 mg) at bedtime; prescribed elsewhere for years; continued by this clinic at the verified dose, seven days at a time, until a supervised withdrawal is planned with addiction medicineTwo capsules at bedtime; no extra dosesOral route2026-06-22 to 2026-07-06completedS
Dextroamphetamine 10 mg oral tablet, one tablet each morning; no extra doses; prescribed elsewhere for weight and energyOne tablet each morningOral route2026-06-22 to 2026-07-20completedS
Dextroamphetamine 5 mg oral tablet, one tablet each morning for two weeks, then stopOne tablet each morning for two weeks, then stopOral route2026-07-20 to 2026-08-03completedS
Sertraline 25 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-22 to 2026-06-29completedS
Sertraline 50 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-06-29activeS
Phenobarbital 32.4 mg oral tablet, one tablet three times daily (97.2 mg a day), started in hospital in place of secobarbitalOne tablet three times dailyOral route2026-07-06 to 2026-07-20completedS
Phenobarbital 16.2 mg oral tablet on a written taper schedule in two or three divided doses: 81 mg a day from the four-week visit, lowered by 8.1 to 16.2 mg about every two weeks and paused when needed; dispensed two weeks at a timePer the written taper schedule, in two or three divided dosesOral route2026-07-20activeS
Medroxyprogesterone acetate 150 mg/mL injection, 150 mg into the muscle every 13 weeks150 mg intramuscularly every 13 weeksIntramuscular route2026-06-22activeS
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for throat pain, no more than 3,000 mg a day, for up to five daysTwo tablets every 6 hours as needed, up to 3,000 mg a dayOral route2026-08-17 to 2026-08-22completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-08-17Body height151cmS
2026-08-17Body weight48.4kgS
2026-08-17Body mass index (BMI) [Ratio]21.2kg/m2S
2026-08-17Systolic blood pressure116mm[Hg]S
2026-08-17Diastolic blood pressure74mm[Hg]S
2026-08-17Heart rate84/minS
2026-08-17Respiratory rate16/minS
2026-08-17Body temperature37.6CelS
2026-08-17Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 2026-08-17; see the Vital Signs section. [S]

SystemFinding
GeneralWell-appearing; speaks in a soft, hoarse voice; temperature 37.6 °C, pulse 84, blood pressure 116/74, oxygen saturation 98%
Ears, nose, mouth, and throatMild redness of the throat without exudate; tonsils not enlarged; nasal mucosa swollen with clear discharge; ear drums normal
NeckSmall tender nodes on both sides; no stridor; neck supple
RespiratoryClear to auscultation; no wheeze
NeurologicalNo tremor
PsychiatricAnxious about work; no signs of sedation or withdrawal

Problems

ProblemClinical statusVerificationCodeProvenance
Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pillsactiveconfirmed F13.20S — Synthetic modern coding. Tolerance and withdrawal are not counted toward the diagnosis for a medicine taken under medical supervision; five other criteria are met. Person-first language; not a claim about her real diagnosis.
Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pillsactiveconfirmed F15.10S — Synthetic modern coding; DSM-5-TR mild stimulant use disorder maps to F15.10. Tolerance and withdrawal are not counted for a supervised prescription.
Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescenceactiveconfirmed G47.00S — Synthetic modern diagnosis anchored to the documented sleeping pills.
Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implantsactiveconfirmed Z30.013S — Synthetic contraception need; the birth is documented.
Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomaniaactiveconfirmed F32.1S — Synthetic modern diagnosis; not a claim about her real mood. The roster's bipolar disorder lead is not supported by the sources read and is not used.
Acute laryngitis, probably viral, during rehearsals, treated with voice rest and supportive care; resolvedresolvedconfirmed J04.0S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Guideline basis: Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Clinical Practice Guideline: Hoarseness (Dysphonia) (Update) (2018)

Follow-up: Phone check in three days. Ten-week review in two weeks. Return sooner for trouble breathing or swallowing, or a high fever. Next scheduled visit 2026-08-31: ten-week review: phenobarbital taper, life after stopping the stimulant, sleep, mood, weight and work. [S]